Arcam completes new share issue of approximately SEK 250 million directed to the First AP-fund

Arcam AB (publ) (“Arcam” or the “Company”) today announces that it has completed
a directed new share issue of 1 799 999 new shares directed to the First AP
-fund, providing the Company with approximately SEK 250 million before
transaction costs.
On May 27, 2015 the Board of Directors has resolved, pursuant to the
authorisation granted by the annual meeting held on March 23, 2015, on a
directed issue of 1,799,999 new shares at a subscription price of SEK 139 per
share. The subscription price represents a premium of approximately 3 per cent
compared to the 5 to 20 days volume weighted average closing price prior to the
Board of Directors’ resolution, and a discount of approximately 4 per cent
compared to the closing price on May 27, 2015.

The proceeds from the directed issue will be used to finance and facilitate
accelerated expansion, acquisition opportunities and development of the Company,
its markets and products.

The Board considers it positive that the First AP-fund becomes a new major
shareholder of the Company. The first AP-fund represents a committed and long
-term institutional owner which the Board believes will contribute positively to
the Company's development. The new share issue represents an opportunity for the
Company to raise capital efficiently and on favourable terms, for the above
-mentioned purposes, and thus enhances the Company's opportunities to create
additional value for all shareholders.

The new issue results in a share dilution of approximately 8.8 per cent. Through
the issue, the number of shares in Arcam increases by 1 799 999 from 18 665 240
to 20 465 239 and the share capital increases by SEK 1799 999.14 from
SEK 18 665 241.50 to SEK 20 465 240.64.

For further information:

Magnus René, CEO, Arcam AB, phone: +46 31 710 32 00,

cell: +46 702 79 89 99, or e-mail: magnus.rene@arcam.com

Important information

Issuance, publication or distribution of this press release in certain
jurisdictions could be subject to restrictions. The recipient of this press
release is responsible for using this press release and the constituent
information in accordance with the rules and regulations prevailing in the
particular jurisdiction. This press release does not constitute an offer or an
offering to acquire or subscribe for any Arcam AB (publ) securities in any
jurisdiction, neither from Arcam AB (publ) nor anyone else.

The above information has been made public in accordance with the Securities
Market Act and/or the Financial Instruments Trading Act. The information was
published on 28 May 2015 at 8.30 AM.
For further information please contact:
Magnus René, CEO Arcam AB
Tel: 46 31 710 32 00, alt. cell: 46 702 79 89 99, or e-mail:
magnus.rene@arcam.com
Arcam Group provides cost-efficient Additive Manufacturing solutions for
production of metal components. Arcam’s Electron Beam Melting (EBM®) technology
offers design freedom combined with excellent material properties and high
productivity. Arcam is, through its solution orientation and comprehensive
product offering, an innovative partner for advanced manufacturing, primarily
for the aerospace and medical industries. Arcam offers EBM systems through Arcam
AB in Sweden, powder metals through AP&C in Canada and implant contract
manufacturing through DiSanto in the U.S.The company is listed on Nasdaq
Stockholm and the Head Office is located in Mölndal, Sweden.

________________________________________________________________________________
_ 
_______

Arcam AB • Krokslätts Fabriker 27A • SE-431 37 Mölndal, Sweden • 46-31-710 32 00
• www.arcam.com